Drug intelligence / Profile preview

Xiaokeqing granule

Development stage
Phase 1
Lead developer
Tasly Pharmaceutical
Administration
Oral
01

Overview

Xiaokeqing granule is a Traditional Chinese Medicine (TCM) herbal formulation developed by The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine. It is currently under clinical investigation for the management of prediabetes and the prevention of progression to type 2 diabetes mellitus. The granule is designed to improve glycemic parameters, including fasting blood glucose, postprandial blood glucose, and HbA1c, while also addressing traditional Chinese medicine syndrome scores related to "Xiaoke" (wasting-thirst syndrome). As a TCM preparation, it likely exerts its therapeutic effects through a multi-component approach to modulate glucose metabolism and insulin sensitivity.

Brand names
Xiaokeqing Granules
Other names
Xiaokeqing granules消渴清颗粒
02

Targets

FGF2SLC2A4 (Solute carrier family 2 facilitated glucose transporter member 4)JUN (Transcription factor Jun)NOS3 (eNOS)SRC (Proto-oncogene tyrosine-protein kinase Src)HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))HTR2C (5-hydroxytryptamine 2C receptor)SERT (Sodium-dependent serotonin transporter)

Beyond the preview

Go deeper on Xiaokeqing granule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xiaokeqing granule.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call